Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 132,418 | 105,635 | 87,622 | 125,332 | 97,251 |
| Marketable Securities | 98,509 | 196,578 | 281,289 | 330,454 | 420,776 |
| Receivables | 27,663 | 24,024 | 32,604 | 26,644 | 14,317 |
| Inventories | 33,233 | 33,209 | 27,723 | 23,943 | 14,647 |
| TOTAL | $368,835 | $435,915 | $514,577 | $574,250 | $615,773 |
| Non-Current Assets | |||||
| PPE Net | 61,908 | 63,563 | 66,851 | 66,467 | 57,970 |
| Intangibles | 18,976 | 19,809 | 20,283 | 12,933 | 12,475 |
| Other Non-Current Assets | 77,346 | 69,781 | 60,236 | 67,331 | 60,120 |
| TOTAL | $158,230 | $153,153 | $147,370 | $146,731 | $130,565 |
| Total Assets | $527,065 | $589,068 | $661,947 | $720,981 | $746,338 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,872 | 3,083 | 10,967 | 5,408 | 4,457 |
| Accrued Expenses | 46,766 | 55,792 | 52,264 | 51,366 | 49,659 |
| Other current liabilities | 11,900 | 10,000 | 7,400 | 6,000 | 4,800 |
| TOTAL | $63,599 | $73,440 | $83,071 | $68,151 | $66,615 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 7,612 | 2,100 | 4,725 |
| Other Non-Current Liabilities | 354,640 | 337,499 | 313,424 | 306,366 | 308,615 |
| TOTAL | $354,640 | $337,499 | $313,424 | $306,366 | $308,615 |
| Total Liabilities | $418,239 | $410,939 | $396,495 | $374,517 | $375,230 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 266,156 | 266,143 | 266,143 | 266,141 | 266,141 |
| Common Shares | 12 | 12 | 12 | 12 | 12 |
| Retained earnings | -1,458,350 | -1,386,752 | -1,296,420 | -1,217,302 | -1,169,385 |
| Other shareholders' equity | -6,509 | -5,238 | -4,802 | 980 | -17,988 |
| TOTAL | $108,826 | $178,129 | $265,452 | $346,464 | $371,108 |
| Total Liabilities And Equity | $527,065 | $589,068 | $661,947 | $720,981 | $746,338 |